Beyazit Bestami | Biomedical and Healthcare Applications | Best Research Article Award

Published on by Computer Vision Awards

Best Research Article Award

Beyazit Bestami — Istanbul Technical University
Beyazit Bestami
Researcher Beyazit Bestami
Affiliation Istanbul Technical University
Country Turkey
Scopus ID 57221928158
Documents 4
Citations 5
h-index 2
Subject Area Biomedical and Healthcare Applications
Event Global Tech Excellence Awards

Beyazit Bestami is a researcher affiliated with Istanbul Technical University, recognized for scholarly contributions in the field of biomedical and healthcare applications. The academic profile associated with Scopus Author ID 57221928158 reflects participation in interdisciplinary technological research with a focus on scientific innovation, healthcare systems, and emerging biomedical methodologies.[1] The researcher’s publication record demonstrates engagement with applied research themes relevant to modern healthcare technologies and engineering-driven biomedical solutions.[2]

Abstract

The recognition associated with the Best Research Article Award acknowledges scholarly work demonstrating scientific relevance, methodological rigor, and interdisciplinary contribution within biomedical and healthcare applications. Beyazit Bestami’s academic activities reflect engagement with contemporary technological approaches in healthcare-oriented research, including analytical frameworks, biomedical innovation, and scientific dissemination.[1] The researcher’s publication and citation metrics indicate developing research visibility within international academic indexing systems and demonstrate alignment with emerging global research priorities in healthcare technologies.[3]

Keywords

Biomedical engineering, healthcare applications, interdisciplinary research, scientific innovation, Scopus indexed research, healthcare technology, biomedical systems, academic recognition, engineering applications, research impact.

Introduction

Academic recognition programs within technology and healthcare sectors aim to identify researchers whose work contributes to scientific advancement and interdisciplinary innovation. Biomedical and healthcare applications remain among the most rapidly evolving research domains due to the integration of computational methods, engineering systems, and healthcare analytics.[4] Researchers working within these fields contribute to improvements in healthcare accessibility, diagnostic systems, medical technologies, and scientific methodologies relevant to global health challenges.

Beyazit Bestami’s scholarly profile reflects participation in these broader academic developments through publications indexed within recognized research databases. The researcher’s institutional affiliation with Istanbul Technical University situates the work within a prominent engineering and technology-oriented academic environment recognized for interdisciplinary scientific research.[2]

Research Profile

The academic profile associated with Scopus Author ID 57221928158 demonstrates a research trajectory focused on biomedical and healthcare applications. The researcher has produced indexed scholarly outputs contributing to the dissemination of applied scientific knowledge within healthcare-oriented technological frameworks.[1]

  • Affiliated with Istanbul Technical University, Turkey.
  • Research activity associated with biomedical and healthcare application domains.
  • Indexed scholarly documents recorded within the Scopus database.
  • Demonstrated citation activity reflecting academic visibility.
  • Participation in interdisciplinary scientific and engineering research initiatives.

The research indicators, including publication count, citation performance, and h-index metrics, collectively illustrate a developing academic profile with emerging influence in specialized biomedical research environments.[3]

Research Contributions

Research contributions within biomedical and healthcare applications frequently involve the integration of engineering methodologies, computational systems, and medical research principles. Beyazit Bestami’s scholarly engagement reflects interdisciplinary participation in scientific initiatives designed to address healthcare-related technological challenges.[2]

  • Contribution to healthcare-oriented scientific investigations and analytical studies.
  • Participation in interdisciplinary biomedical engineering research environments.
  • Support for scientific dissemination through indexed academic publications.
  • Engagement with research methodologies relevant to healthcare innovation and technology integration.
  • Development of scholarly outputs contributing to biomedical application research visibility.

The interdisciplinary nature of biomedical engineering and healthcare applications requires collaborative integration of engineering sciences, computational technologies, and healthcare systems research. Such academic contributions remain essential for advancing practical and evidence-based healthcare innovations.[5]

Publications

The publication profile indexed under the Scopus author record demonstrates scholarly engagement through peer-reviewed academic outputs related to healthcare technologies and biomedical applications.[1] Representative publication themes include biomedical methodologies, healthcare-oriented engineering systems, and interdisciplinary scientific studies.

  1. Research articles associated with biomedical engineering and healthcare systems.
  2. Scientific publications indexed within international academic databases.
  3. Interdisciplinary studies integrating engineering methodologies and healthcare applications.
  4. Scholarly outputs contributing to healthcare technology research visibility.

Digital scholarly dissemination through DOI-linked publications enhances accessibility and citation visibility within global research ecosystems.[6]

Research Impact

Research impact is commonly evaluated through citation indicators, scholarly indexing, publication quality, and interdisciplinary relevance. The available metrics associated with Beyazit Bestami’s academic profile indicate measurable scholarly engagement within biomedical and healthcare research environments.[3]

  • Scopus-indexed documents: 4
  • Total citations: 5
  • h-index: 2
  • Institutional association with a globally recognized technical university.
  • Academic contribution to biomedical and healthcare-related scientific domains.

Although the publication portfolio represents an emerging academic trajectory, the existing research indicators demonstrate early-stage scholarly influence and continuing participation in biomedical and healthcare application research activities.[4]

Award Suitability

The Global Tech Excellence Awards recognizes scientific contributions that demonstrate innovation, technical relevance, and interdisciplinary significance. Beyazit Bestami’s research profile aligns with the objectives of the Best Research Article Award through demonstrated involvement in healthcare-oriented technological research and scientific dissemination.[7]

Several aspects support suitability for recognition:

  • Research activity within the high-impact field of biomedical and healthcare applications.
  • Indexed publications demonstrating scholarly participation.
  • Interdisciplinary academic engagement involving engineering and healthcare systems.
  • Contribution to scientific communication through recognized academic databases.
  • Institutional affiliation with a major international technical university.

Recognition through international academic awards can further strengthen visibility, encourage interdisciplinary collaboration, and support continued contributions to biomedical innovation and healthcare-oriented scientific advancement.[5]

Conclusion

Beyazit Bestami’s academic profile reflects emerging scholarly contributions within biomedical and healthcare applications, supported by indexed publications, citation activity, and interdisciplinary research engagement. The researcher’s affiliation with Istanbul Technical University and participation in healthcare-oriented scientific research align with the objectives of international academic recognition initiatives such as the Global Tech Excellence Awards.[1] Continued research development and scientific dissemination may further strengthen the academic impact and visibility of future contributions within the biomedical technology domain.

References

    1. Elsevier. (n.d.). Scopus author details: Beyazit Bestami, Author ID 57221928158. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=57221928158
    2. Istanbul Technical University. (n.d.). Institutional research and academic overview.
      https://www.itu.edu.tr/en/homepage
    3. Yüksel, B. B., & Metin, A. Y. (2026). HEART: A High-Efficiency Adaptive Real-Time Telemonitoring Framework for Secure Electrocardiogram Signal Transmission Using Chaotic Encryption. ELECTRICA.
      DOI:https://doi.org/10.5152/electrica.2026.25232
    4. Yüksel, B. B., & Metin, A. Y. (2026). Artificial Intelligence Breakthroughs and Data Futures: A Retrospective and Prospective Review. Academic Platform Journal of Engineering and Smart Systems.
      DOI:https://doi.org/10.21541/apjess.1705042
    5. Yuksel, B. B., & Yilmazer-Metin, A. (2024). ECG-PPS: Privacy Preserving Disease Diagnosis and Monitoring System for Real-Time ECG Signals. In 2024 17th International Conference on Security of Information and Networks (SIN).
      DOI:https://doi.org/10.1109/SIN63213.2024.10871599
    6. Yuksel, B. B., Bahtiyar, S., & Yilmazer, A. (2020). Credit Card Fraud Detection with NCA Dimensionality Reduction. In 13th International Conference on Security of Information and Networks.
      DOI:https://doi.org/10.1145/3433174.3433178
    7. Global Tech Excellence Awards. (n.d.). Award categories and academic recognition criteria.
      https://globaltechexcellence.com/

Neven Saleh | Healthcare Engineering Systems | Women Researcher Award

Published on by Computer Vision Awards

Assist. Prof. Dr. Neven Saleh | Healthcare Engineering Systems | Women Researcher Award

Associate Professor | Future University in Egypt | Egypt

Assist. Prof. Dr. Neven Saleh is a highly motivated and detail-oriented researcher with extensive experience in biomedical engineering, machine learning, deep learning for disease diagnosis, healthcare technology, hospital design, and assistive communication systems. She holds a Ph.D. in Biomedical Engineering from Politecnico di Torino and a master’s and bachelor’s degree in biomedical and electronics engineering from Egyptian universities. She has served as an associate professor at multiple institutions, supervised numerous Ph.D. and M.Sc. students, and contributed to international research collaborations across Italy, Egypt, and the USA. Her research interests focus on AI-driven diagnostic systems for retinal and neurological disorders, cancer detection using image processing, healthcare technology assessment, hospital workflow optimization, and assistive technologies for patients with disabilities. She has received multiple awards and honors for her innovative projects, teaching excellence, and scientific contributions, including national competitions, best thesis awards, and international conference recognitions. She possesses strong research skills in machine learning, deep learning, computer vision, biomedical signal processing, medical instrumentation, and healthcare technology management. She is a member of professional organizations such as TWAS-OWSD and IFMBE and has completed advanced certifications in machine learning, clinical engineering, and healthcare quality management. Her research impact is reflected in 277 citations by 204 documents, 41 publications, and an h-index of 9.

Profile: Google Scholar | Scopus | ORCID

Featured Publications

  1. Saleh, N., Sharawi, A. A., Abd Elwahed, M., Petti, A., Puppato, D., & Balestra, G. (2014). Preventive maintenance prioritization index of medical equipment using quality function deployment. IEEE Journal of Biomedical and Health Informatics, 19(3), 1029–1035.

  2. Saleh, N., Abdel Wahed, M., & Salaheldin, A. M. (2022). Transfer learning‐based platform for detecting multi‐classification retinal disorders using optical coherence tomography images. International Journal of Imaging Systems and Technology, 32(3), 740–752.

  3. Saleh, N., Farghaly, M., Elshaaer, E., & Mousa, A. (2020). Smart glove-based gestures recognition system for Arabic sign language. In 2020 International Conference on Innovative Trends in Communication and … (pp. 37–…).

  4. Saleh, N., Hassan, M. A., & Salaheldin, A. M. (2024). Skin cancer classification based on an optimized convolutional neural network and multicriteria decision-making. Scientific Reports, 14(1), 17323.

  5. Salaheldin, A. M., Abdel Wahed, M., Talaat, M., & Saleh, N. (2024). Deep learning‐based automated detection and grading of papilledema from OCT images: A promising approach for improved clinical diagnosis and management. International Journal of Imaging Systems and Technology, 34(4), e23133.

Dr. Rainer Hubmann | Biomedical and Healthcare Applications | Best Researcher Award

Published on by Computer Vision Awards

Dr. Rainer Hubmann | Biomedical and Healthcare Applications | Best Researcher Award

Doctorate at Red Cross | Austria

Mag. Dr. Rainer Hubmann embarked on his academic journey at the University of Vienna, earning his master’s degree in Biology/Genetics in 1996. During this time, he became an active member of the Cell Cycle Club under the leadership of Kim Nasmyth at the Research Institute of Molecular Pathology (IMP). His passion for molecular biology led him to pursue his Ph.D. at the Medical University of Vienna, where he focused on the regulation of CD23 in Chronic Lymphocytic Leukemia (CLL), completing it in 2002.

Professional Profiles

Scopus

Orcid

🎓Education and Academic Background

Dr. Rainer Hubmann’s distinguished academic journey began at the University of Vienna, where he earned a Master’s degree in Biology and Genetics (1987–1996). During this time, he joined the prestigious Cell Cycle Club, led by Kim Nasmyth, sharpening his focus on cell cycle research. He pursued his Ph.D. thesis (1997–2002) at the Medical University of Vienna (MUW), investigating the Regulation of CD23 in Chronic Lymphocytic Leukemia (CLL). His postdoctoral work from 2002 to 2011 extended into pioneering studies on NOTCH2 regulation and the characterization of CLL stem cells. In 2022, he assumed the role of Group Leader and Senior Scientist at the Division of Hematology and Hemostaseology, MUW, further solidifying his leadership in hematological research.

🔬 Research and Innovation

Dr. Hubmann’s research has made groundbreaking strides in NOTCH signaling and its implications in cancer. His work elucidates the central role of NOTCH2 signaling in CLL leukemogenesis, uncovering vital mechanisms of disease progression. He has identified GLIOTOXIN as a potent therapeutic NOTCH2/CSL transactivation inhibitor, presenting it as a promising alternative to conventional γ-secretase inhibitors. Furthermore, he discovered a tumor-suppressor role for NOTCH3 signaling in CLL, revealing its therapeutic potential. Dr. Hubmann’s studies have highlighted the recurring NOTCH2ΔNRR gain-of-function (GOF) mRNA deletions as potentially disease-defining genetic lesions in CLL. His innovative research also explores somatic recombination involving ancient and recent NOTCH2 gene variants, addressing hereditary, geographic, and gender-based variations.

🧪 Patents and Innovations

Dr. Hubmann’s contributions to translational medicine are protected by several patents. These include Gliotoxin for the treatment of NOTCH2-associated malignancies (WO/2006/135949; US Patent No 7,981,878) and NOTCH21A01/1a4-RFLP as a leukemia/tumor predisposition detection tool (MUW Tech-ID: 835.19). His patented innovations underscore his role in translating basic research into clinical applications.

💡 Technical Expertise

Dr. Hubmann possesses advanced technical skills pivotal to hematology and oncology research. His expertise includes gene expression and silencing techniques such as retroviral vectors and siRNA-mediated gene silencing. He is proficient in molecular analysis, including RT-PCR, Northern & Western blotting, and RNA-seq sequence analysis. His work extends to drug screening models, xenograft mouse models, and developing diagnostic tools for personalized medicine. His ability to blend bioinformatics with preclinical studies further enhances his contributions to the field.

💵 Funding and Grants

Over his career, Dr. Hubmann has secured significant funding for his research. Notable grants include FWF P15100 (2001) for studying the Regulation and Function of NOTCH2 in CLL, and ÖNB Jubiläumsfonds (2002, 2004) for exploring NOTCH2 in leukemogenesis. His work on GLIOTOXIN’s therapeutic potential was supported by Initiative Krebsforschung (2013), while his recent studies on NOTCH2ΔNRR deletions were funded by the Fellinger Krebsforschungsfonds (2022). These funding milestones reflect the impact and importance of his research.

🏆 Awards and Recognition

Dr. Hubmann’s outstanding contributions to medical research have earned him numerous accolades. In 1999, he received the Aventis Stiftung Award for his work on fibroblast growth factor in Hairy Cell Leukemia. His innovative findings on interferon-alpha in Hairy Cell Leukemia earned the Erste Bank Preis in 2001. In 2005 and 2010, he was awarded the Sanofi-Aventis Prize for breakthroughs in cancer therapy and PI3-K/Akt/CK2 signaling. Additionally, the Paracelsus Medical University Award (2008) recognized his research on TGF-β in Radon therapy for Ankylosing Spondylitis patients.

🏢 Professional Memberships

Dr. Hubmann is an esteemed member of the Austrian Society for Hematology and Oncology (ÖGHO). He serves as the Vice Coordinator of the Comprehensive Cancer Center Vienna (CCC) Research Cluster, focusing on Microenvironment, Vasculature, and Metastasis, underscoring his leadership in advancing cancer research.

🎓 Teaching and Mentorship

Since 1998, Dr. Hubmann has played a pivotal role in teaching and mentoring young scientists. He leads specialized courses, including Molecular Biology in Hematology-Oncology and Clinical and Experimental Hematology, since 2001. His dedication extends to supervising Ph.D. and diploma students, nurturing the next generation of researchers and clinicians.

Publications Top Noted📚 

Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL Cells

Authors: Rainer Hubmann

Journal: Cells

Year: 2020

UGT2B17 modifies drug response in chronic lymphocytic leukaemia

Authors: Rainer Hubmann

Journal: British Journal of Cancer

Year: 2020

Combined approach for characterization and quality assessment of rabbit bone marrow-derived mesenchymal stem cells intended for gene banking

Authors: Rainer Hubmann

Journal: New Biotechnology

Year: 2020

Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL

Authors: Rainer Hubmann

Journal: Nature Chemical Biology

Year: 2019

Critical assessment of the efficiency of CD34 and CD133 antibodies for enrichment of rabbit hematopoietic stem cells

Authors: Rainer Hubmann

Journal: Biotechnology Progress

Year: 2018